A New Year, but the Same Old Stock Market
The new year was to have brought a new beginning for China's stock market. Instead, investors who were set to welcome the return of IPO action after a suspension of 14 months were disappointed by news on January 10 that Jiangsu Aosaikang Pharmaceutical Co. Ltd. was putting its anticipated initial public offering on hold.
The abrupt postponement has sparked questions about the regulator's reform agenda. Clearly, at a time when it is trying to clarify its own role vis-à-vis the market, the regulator has yet to master the art of timing. Xiao Gang, chairman of the China Securities Regulatory Commission, said at a work conference this month that reform will see a complete overhaul of the regulator's scope of oversight of the capital market. Its recent actions must be seen in light of this pledge.
- Black Holes
- Mecca: The Sacred City
- Graphics: China's Overworked Workers
- Capital's Gov't Says Subway Fares Will Double Starting December
- Despite Minor Disputes, Ties with China Best in History, German Envoy Says
- "Happiest People"
- Wal-Mart Says It Has Laid Off 28 Managers, 90 Others
- Robot Waiter
- Nanning Stabbings
- Another Brother in Prominent Shanxi Family Is Target of Graft Investigation
- Sign up to receive our free daily newsletter
- The Low Official Found with Towering Pile of Cash, Gold and Properties
- Clearing the Air with a Sino-U.S. Climate Pact
- At Factory Waste Ponds, Fumes Choke Fantasies
- Justin Lin Ignores Population Factor with Growth Predictions
- Canceled Mexican Rail Contract Gives Chinese Firms Chance to Reflect
- Websites Offering Subtitles for Foreign TV Shows, Movies Shut Down
- China Needs All-Out Effort to Meet Emissions Goals, Experts Say
- A Passage to India
- Court to Rehear 1996 Murder Case that Ended with Suspect's Execution
- Scientists Issue Warning over Development of Coastal Wetlands